Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mimi I Hu

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Bone|February 25, 2021
Adverse events associated with bone-directed therapies in patients with cancerMark A Jara, Jeena Varghese, Mimi I Hu
Endocrinology and Metabolism Clinics of North America|June 4, 2014
Update on medullary thyroid cancerMimi I Hu, Anita K Ying, Camilo Jimenez
Current Osteoporosis Reports|April 24, 2008
Bone loss in patients with breast or prostate cancerMimi I Hu, Robert F Gagel, Camilo Jimenez
Thyroid : Official Journal of the American Thyroid Association|March 24, 2023
<i>Letter to the Editor: ETV6-NTRK2</i> Fusion Identified in a Patient with Medullary Thyroid CarcinomaOmar Alsharif, Timothy Panella, Laurentia Nodit, et al.
Journal of the National Cancer Institute|June 8, 2014
ResponseIlya G Glezerman, Mimi I Hu, Rajul K Jain
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 8, 2010
Medical management of postsurgical hypoparathyroidismMaryam I Khan, Steven G Waguespack, Mimi I Hu
Head & Neck|April 22, 2024
Reply to Letter to the Editor regarding "Decreased utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer"Anastasios Maniakas, Mimi I Hu, G Brandon Gunn, et al.
CA: a Cancer Journal for Clinicians|September 22, 2018
Hypercalcemia and cancer: Differential diagnosis and treatmentJonathan Zagzag, Mimi I Hu, Sarah B Fisher, et al.
Journal of Cancer Survivorship : Research and Practice|May 5, 2009
Skeletal sequelae of cancer and cancer treatmentCharles J Stava, Camilo Jimenez, Mimi I Hu, et al.
Journal of Thyroid Research|October 19, 2011
Challenges associated with tyrosine kinase inhibitor therapy for metastatic thyroid cancerMaria E Cabanillas, Mimi I Hu, Jean-Bernard Durand, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Bone|February 25, 2021
Adverse events associated with bone-directed therapies in patients with cancerMark A Jara, Jeena Varghese, Mimi I Hu
Endocrinology and Metabolism Clinics of North America|June 4, 2014
Update on medullary thyroid cancerMimi I Hu, Anita K Ying, Camilo Jimenez
Current Osteoporosis Reports|April 24, 2008
Bone loss in patients with breast or prostate cancerMimi I Hu, Robert F Gagel, Camilo Jimenez
Thyroid : Official Journal of the American Thyroid Association|March 24, 2023
<i>Letter to the Editor: ETV6-NTRK2</i> Fusion Identified in a Patient with Medullary Thyroid CarcinomaOmar Alsharif, Timothy Panella, Laurentia Nodit, et al.
Journal of the National Cancer Institute|June 8, 2014
ResponseIlya G Glezerman, Mimi I Hu, Rajul K Jain
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 8, 2010
Medical management of postsurgical hypoparathyroidismMaryam I Khan, Steven G Waguespack, Mimi I Hu
Head & Neck|April 22, 2024
Reply to Letter to the Editor regarding "Decreased utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer"Anastasios Maniakas, Mimi I Hu, G Brandon Gunn, et al.
CA: a Cancer Journal for Clinicians|September 22, 2018
Hypercalcemia and cancer: Differential diagnosis and treatmentJonathan Zagzag, Mimi I Hu, Sarah B Fisher, et al.
Journal of Cancer Survivorship : Research and Practice|May 5, 2009
Skeletal sequelae of cancer and cancer treatmentCharles J Stava, Camilo Jimenez, Mimi I Hu, et al.
Journal of Thyroid Research|October 19, 2011
Challenges associated with tyrosine kinase inhibitor therapy for metastatic thyroid cancerMaria E Cabanillas, Mimi I Hu, Jean-Bernard Durand, et al.
Pageof 10